September 16, 2011 -- Avenue Capital Group, a New York-based hedge fund and private equity investor, has teamed up with China Medical City in Taizhou to form a healthcare industry investment fund. It plans to raise $313 million, of which $157 million will be available by the end of this year. The PE fund will invest in CROs, biopharmas, drug distributors, medical device makers and hospital companies – all of them located in China Medical City. More details....
